Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OrthoPediatrics Lowers FY2025 Sales Guidance from $237.000M-$242.000M to $233.500M-$234.500M vs $239.440M Est

Author: Benzinga Newsdesk | October 09, 2025 03:53pm
OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 million vs $239.440 million estimate.

Posted In: KIDS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist